122 related articles for article (PubMed ID: 690703)
1. Uptake of Tc-99m monophosphate complexes in bone and myocardial necrosis in animals.
Kung HF; Ackerhalt R; Blau M
J Nucl Med; 1978 Sep; 19(9):1027-31. PubMed ID: 690703
[TBL] [Abstract][Full Text] [Related]
2. Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes.
Subramanian G; McAfee JG; Blair RJ; Kallfelz FA; Thomas FD
J Nucl Med; 1975 Aug; 16(8):744-55. PubMed ID: 170385
[TBL] [Abstract][Full Text] [Related]
3. Tc-99m methylene diphosphonate versus Tc-99m pyrophosphate: biologic and clinical comparison.
Rudd TG; Allen DR; Hartnett DE
J Nucl Med; 1977 Sep; 18(9):872-6. PubMed ID: 197133
[TBL] [Abstract][Full Text] [Related]
4. Sites and mechanisms of localization of technetium-99m phosphorus radiopharmaceuticals in acute myocardial infarcts and other tissues.
Buja LM; Tofe AJ; Kulkarni PV; Mukherjee A; Parkey RW; Francis MD; Bonte FJ; Willerson JT
J Clin Invest; 1977 Sep; 60(3):724-40. PubMed ID: 893676
[TBL] [Abstract][Full Text] [Related]
5. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging?
Kumar V; Kumar D; Howman-Giles RB; Little DG
Nucl Med Commun; 2007 Feb; 28(2):101-7. PubMed ID: 17198350
[TBL] [Abstract][Full Text] [Related]
6. Uptake of technetium-99m methylene diphosphonate by fractured and osteoporotic bone after a pulse dose of vitamin D3.
Carr EA; Carroll M; Montes M; Zielezny M
J Nucl Med; 1985 Apr; 26(4):385-9. PubMed ID: 2984363
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m-labeled stannous imidodiphosphate, a new radiodiagnostic agent for bone scanning: comparison with other 99mTc complexes.
Subramanian G; McAfee JG; Blair RJ; Rosenstreich M; Coco M; Duxbury CE
J Nucl Med; 1975 Dec; 16(12):1137-43. PubMed ID: 1194964
[TBL] [Abstract][Full Text] [Related]
8. Technetium-99m phytate as a bone-marrow imaging agent: biodistribution studies in animals: concise communication.
Hamilton RG; Alderson PO; Mclntyre PA
J Nucl Med; 1977 Jun; 18(6):563-5. PubMed ID: 859038
[TBL] [Abstract][Full Text] [Related]
9. Binding of technetium-99m to plasma proteins: influence on the distribution of Tc-99m phosphate agents.
Schümichen C; Koch K; Kraus A; Kuhlicke G; Weiler K; Wenn A; Hoffman G
J Nucl Med; 1980 Nov; 21(11):1080-5. PubMed ID: 7431108
[TBL] [Abstract][Full Text] [Related]
10. Studies of skeletal tracer kinetics. III. Tc-99m(Sn)methylenediphosphonate uptake in the canine tibia as a function of blood flow.
Sagar VV; Piccone JM; Charkes ND
J Nucl Med; 1979 Dec; 20(12):1257-61. PubMed ID: 536792
[TBL] [Abstract][Full Text] [Related]
11. Necrosis avidity of (99m)Tc(CO)3-labeled pamoic acid derivatives: synthesis and preliminary biological evaluation in animal models of necrosis.
Fonge H; Chitneni SK; Lixin J; Vunckx K; Prinsen K; Nuyts J; Mortelmans L; Bormans G; Ni Y; Verbruggen A
Bioconjug Chem; 2007; 18(6):1924-34. PubMed ID: 17929883
[TBL] [Abstract][Full Text] [Related]
12. [Comparative evaluation of the accumulation of 99mTc-labeled phosphate compounds in the bones].
Atamaniuk NP; Mechev DS
Eksp Onkol; 1985; 7(1):66-7. PubMed ID: 2983974
[TBL] [Abstract][Full Text] [Related]
13. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
[TBL] [Abstract][Full Text] [Related]
14. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
15. Bone accumulation of the Tc-99m complex of carbamyl phosphate and its analogs.
Hosain P; Spencer RP; Ahlquist KJ; Sripada PK
J Nucl Med; 1978 May; 19(5):530-3. PubMed ID: 641577
[TBL] [Abstract][Full Text] [Related]
16. Chemistry of technetium radiopharmaceuticals. I. Exploration of the tissue distribution and oxidation state consequences of technetium (IV) in Tc-Sn-gluconate and Tc-Sn-EHDP using carrier 99Tc.
Hambright P; McRae J; Valk PE; Bearden AJ; Shipley BA
J Nucl Med; 1975 Jun; 16(6):478-82. PubMed ID: 808594
[TBL] [Abstract][Full Text] [Related]
17. Technetium-99m DTPA uptake and transit in bone: effect on blood clearance in rabbits.
Sampson WF
J Nucl Med; 1987 Sep; 28(9):1461-4. PubMed ID: 3305806
[TBL] [Abstract][Full Text] [Related]
18. 99mTc-labelled compounds prepared with sodium dithionite as reducing agent.
Vilcek S; Kalincák M; Machán V
Nuklearmedizin; 1981 Dec; 20(6):283-9. PubMed ID: 6460222
[TBL] [Abstract][Full Text] [Related]
19. [Regional blood flow and bone uptake of methylene-diphosphonate-technetium-99m].
Vattimo A; Martini G; Pisani M
Boll Soc Ital Biol Sper; 1983 May; 59(5):590-5. PubMed ID: 6192828
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, radiotechnetium labelling, and comparison of biologic behavior of longer-chain analogs of methylene diphosphonate.
Wang TS; Hosain P; Spencer RP; Ahlquist K; Hosain F
J Nucl Med; 1978 Oct; 19(10):1151-3. PubMed ID: 722328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
